Use of genetically engineered pancreatic β cells in the treatment of experimentally induced diabetes

R. Stein, B. A. Hicks, A. A. Demetriou

Research output: Chapter in Book/Report/Conference proceedingConference contribution

1 Citation (Scopus)
Original languageEnglish (US)
Title of host publicationXenograft 25
Subtitle of host publicationproceedings of the International Congress, Xenograft 25. ICS880
EditorsM.A. Hardy, M.A. Hardy
PublisherElsevier Science Publishers B.V.
Pages309-317
Number of pages9
ISBN (Print)0444811133
StatePublished - Jan 1 1989
EventThe International Congress, Xenograft 25 -
Duration: Nov 11 1988Nov 13 1988

Other

OtherThe International Congress, Xenograft 25
Period11/11/8811/13/88

Fingerprint

Insulin-Secreting Cells

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Stein, R., Hicks, B. A., & Demetriou, A. A. (1989). Use of genetically engineered pancreatic β cells in the treatment of experimentally induced diabetes. In M. A. Hardy, & M. A. Hardy (Eds.), Xenograft 25: proceedings of the International Congress, Xenograft 25. ICS880 (pp. 309-317). Elsevier Science Publishers B.V..

Use of genetically engineered pancreatic β cells in the treatment of experimentally induced diabetes. / Stein, R.; Hicks, B. A.; Demetriou, A. A.

Xenograft 25: proceedings of the International Congress, Xenograft 25. ICS880. ed. / M.A. Hardy; M.A. Hardy. Elsevier Science Publishers B.V., 1989. p. 309-317.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Stein, R, Hicks, BA & Demetriou, AA 1989, Use of genetically engineered pancreatic β cells in the treatment of experimentally induced diabetes. in MA Hardy & MA Hardy (eds), Xenograft 25: proceedings of the International Congress, Xenograft 25. ICS880. Elsevier Science Publishers B.V., pp. 309-317, The International Congress, Xenograft 25, 11/11/88.
Stein R, Hicks BA, Demetriou AA. Use of genetically engineered pancreatic β cells in the treatment of experimentally induced diabetes. In Hardy MA, Hardy MA, editors, Xenograft 25: proceedings of the International Congress, Xenograft 25. ICS880. Elsevier Science Publishers B.V. 1989. p. 309-317
Stein, R. ; Hicks, B. A. ; Demetriou, A. A. / Use of genetically engineered pancreatic β cells in the treatment of experimentally induced diabetes. Xenograft 25: proceedings of the International Congress, Xenograft 25. ICS880. editor / M.A. Hardy ; M.A. Hardy. Elsevier Science Publishers B.V., 1989. pp. 309-317
@inproceedings{9c8edb668c174fa986135517a671b0bc,
title = "Use of genetically engineered pancreatic β cells in the treatment of experimentally induced diabetes",
author = "R. Stein and Hicks, {B. A.} and Demetriou, {A. A.}",
year = "1989",
month = "1",
day = "1",
language = "English (US)",
isbn = "0444811133",
pages = "309--317",
editor = "M.A. Hardy and M.A. Hardy",
booktitle = "Xenograft 25",
publisher = "Elsevier Science Publishers B.V.",

}

TY - GEN

T1 - Use of genetically engineered pancreatic β cells in the treatment of experimentally induced diabetes

AU - Stein, R.

AU - Hicks, B. A.

AU - Demetriou, A. A.

PY - 1989/1/1

Y1 - 1989/1/1

UR - http://www.scopus.com/inward/record.url?scp=0024444102&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024444102&partnerID=8YFLogxK

M3 - Conference contribution

AN - SCOPUS:0024444102

SN - 0444811133

SP - 309

EP - 317

BT - Xenograft 25

A2 - Hardy, M.A.

A2 - Hardy, M.A.

PB - Elsevier Science Publishers B.V.

ER -